EUVIMEDEUVIMED entdecken
Crossref

Shedding by ADAM10 and ADAM17 is associated with progression of adult T-cell leukemia/lymphoma

Integrative Cancer Science and Therapeutics · 2015

DOI: 10.15761/icst.1000118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Integrative Cancer Science and Therapeutics, 2015.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

(2015). Shedding by ADAM10 and ADAM17 is associated with progression of adult T-cell leukemia/lymphoma. Integrative Cancer Science and Therapeutics. https://doi.org/10.15761/icst.1000118

Vancouver

Shedding by ADAM10 and ADAM17 is associated with progression of adult T-cell leukemia/lymphoma. Integrative Cancer Science and Therapeutics. 2015. doi:10.15761/icst.1000118

BibTeX
@article{euvimed2015,
  title = {Shedding by ADAM10 and ADAM17 is associated with progression of adult T-cell leukemia/lymphoma},
  journal = {Integrative Cancer Science and Therapeutics},
  year = {2015},
  doi = {10.15761/icst.1000118}
}
Kostenlos starten →